middle.news
Botanix Confirms $25M Sales Milestone and Explains ASX Disclosure Delay
3:41pm on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
Botanix Confirms $25M Sales Milestone and Explains ASX Disclosure Delay
3:41pm on Thursday 31st of July, 2025 AEST
Key Points
Gross sales reached approximately AUD 25 million since January 2025
Over 16,000 prescriptions filled across 6,700 patients by June 2025
95% adherence rate in auto-refill program, 79% overall patient adherence
Disclosure timing delayed due to data reconciliation and quality checks
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BOTANIX PHARMACEUTICALS (ASX:BOT)
OPEN ARTICLE